Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cyberonics (cybx) epilepsy therapy recommonded -- Ignore unavailable to you. Want to Upgrade?

To: Valentin who wrote (162)	3/15/1998 5:44:00 PM
From: Dennis	Read Replies (1) \| Respond to of 471

Valentin, WOW You have done your homework, I'm not that number hungry, I know I should be. I tend to look at the uniqueness of the product and total dominance of the market. Medtronic has a similar device BUT it involves going into the brain. Surgery must be very expensive. Production is going to be a problem with such a huge demand. I don't know if Jude will sell, I figure they paid less than $5.00 per share, 2,181,000 shares were bought. Not a bad profit if they do sell. April 18?? I don't know. Waiting for co. to call me. gg I left a message. I think i remember reading somewhere that they went from $8,000 per to $9,000. But don't rely on my aging memory. :o) Good Luck, this one looks like a long term winner